Drag a card by its title · ⚙ to size, swap or remove

The company

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTLB · Nasdaq

Health CareBiotechnologyNot moving yet

XTLB stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 24.3% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 52
Industry in uptrend: 18% -14 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 3 (-2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

21 Apr – 20 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months0

Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders3-2 on the quarter

New · exited1 · 3

Reported value$21K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
RHUMBLINE ADVISERSadded · filed 12 Aug 2026	6,228$17K	+241+4.0%
GAMMA Investing LLCreduced · filed 7 Jul 2026	1,213$3,311	-2,175−64.2%
UBS Group AGnew · filed 13 Aug 2026	125$341	+125